Skip to main content



Dr. Laura Lourdes is board-certified in medical oncology, internal medicine, and hematology, and practices at our Beaches and Southpoint locations. She received her Doctor of Medicine from the Royal College of Surgeons in Ireland and Penang Medical College before completing several internships, residencies, and fellowships at the National University of Singapore, the University of Florida, and Indiana University.

Her UF connection introduced her to the North Florida area and she soon fell in love with it, especially after finding CSNF: “working with colleagues who quickly have become friends is very fulfilling- we all share the same goal of getting patients on the path to wellness,” she says. While, “thankfully”, she’s never had a personal experience with cancer, she still finds it easy to relate to her patients and finds much joy in meeting and helping people from all walks of life.

“I care… a lot,” she says, continuing, “to quote the Dalai Lama, ‘Our prime purpose in life is to help others. And if you can’t help them, at least don’t hurt them.’ This quote and way of thinking has truly influenced my philosophy as an oncologist. I just want to be there for my patients and help them through his difficult journey in any way I can.”

When not in the office, Dr. Lourdes enjoys spending time with her family and hobbies like cooking, running, traveling, and her favorite, gardening. “I find gardening to be similar to taking care of patient,” she says, “you nurture and tend to it, and it produces good results!”

Curriculum Vitae


Internal Medicine
Medical Oncology


American College of Medical Oncologist
American Society of Hematology


Indiana University
Hematology and Oncology


University of Florida
Internal Medicine


National University of Singapore
Medicine, Surgery, & Pediatrics
National University of Singapore
Internal Medicine


Royal College of Surgeons in Ireland and Penang Medical College


Journal of Clinical Oncology
Recurrent dematophytosis (Majocchi Granuloma) associated with chemotherapy-induced neutropenia.
The Oncologist
Circulating Tumor Cells in Lung Cancer
Hoosier Cancer Research Network
Randomized Phase II Trial of Docetaxel plus Nivolumab or Docetaxel alone in patients with advanced non-squamous NSCLC previously treated with single agent Nivolumab